Answers are grounded in this paper and cite their sources.
The present use of mRNA vaccines against COVID-19 has shown for the first time the potential of mRNA vaccines for infectious diseases. Here we will summarize the current knowledge about improved mRNA vaccines, i.e., the self-amplifying mRNA (saRNA) vaccines. This approach may enhance antigen expression by amplification of the antigen-encoding RNA. RNA design, RNA delivery, and the innate immune responses induced by RNA will be reviewed.
No takes yet. Share an insight, caveat, or question.
Schmidt et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: